Equity
€113,635 ▲ 0.2%
Dr. Maréchal Nicolas paid out €50,000 in dividends. That is 100% of the 2025 profit.
Dr. Maréchal Nicolas
Lifetime
4 annual accounts with figures on one time axispeak €67,544 (2025)
€67,544▲ 0.6%
peak €50,916 (2024)
€50,216▼ 1.4%
peak €113,635 (2025)
€113,635▲ 0.2%
€6,627▼ 52.1%
Board1 name since 2022
1 director
Documentsfilings and deeds
16-09-202647 days late
2025micro format
Dividend €50,000Debts from €13,840 to €6,627
Key points
from the 2025 annual accountsTurnover
≈ €150,000 estimated
The micro format states no turnover.
Liquidity
18.05 was 9.10 in 2024
Short-term debts fell from €13,840 to €6,627.
Filings
4 annual accounts 4 late
The 2025 accounts came latest: 47 days after the end of the period.
Starting capital
€3,000 100 shares
Position in the sector
94.5%
Higher solvency than 90% of companies in human health. Sector median 63.0% · 21,311 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 39,326 companies had the same profile as Dr. Maréchal Nicolas has now. Each dot stands for 99 companies, two years later.
95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,326 companies, not a prediction for Dr. Maréchal Nicolas. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0789746482
Incorporation
Founding capital of €3,000, 100 shares · Founder: (comparant) · Appointment: (director) · published on 22-08-2022 · Gazette deed
First establishment
Burgemeester Etienne Demunterl. 17, Jette
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Dr. Maréchal Nicolas Jette | €120,261 | €67,544 | 94.5% | - |
| Medicarl Anderlecht | €121,995 | €69,616 | 65.3% | - |
| Gynécologie Philippe Simon Uccle | €117,676 | €62,790 | 100.0% | - |
| DOCTEUR ARIELLE BLANJEAN Chaudfontaine | €112,784 | €70,526 | 44.9% | - |
| DOCTEUR NATACHA MAWAIT Crisnée | €138,540 | €69,327 | 10.5% | - |
| BOS WAUTERS BÜTTNER Sint-Genesius-Rode | €104,956 | €65,077 | -39.8% | - |
| GL Infexio La Hulpe | €137,066 | €71,746 | 92.6% | - |
These companies have the same main activity as Dr. Maréchal Nicolas: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €105,000 and €139,000, founded between 2022 and 2023.
Official details
Source: KBO- Status
- Active since 18-08-2022Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.334.442.2831090 Jette, since 18-08-2022
- Financial year end
- 31 December
- Peppol
- Reachable since 06-09-2022
Insights on Dr. Maréchal Nicolas
Dr. Maréchal Nicolas files the micro format. That format states no turnover. The gross margin rose from €20,056 in 2022 to €67,544 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Dr. Maréchal Nicolas
- What is the company number of Dr. Maréchal Nicolas?
- The company number of Dr. Maréchal Nicolas is 0789.746.482. The VAT number is the same number with BE in front: BE 0789.746.482.
- Where is Dr. Maréchal Nicolas based?
- The registered office is at Burgemeester Etienne Demunterl. 17, 1090 Jette.Company details
- What does Dr. Maréchal Nicolas do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of Dr. Maréchal Nicolas?
- Dr. Maréchal Nicolas is a private limited company (BV).
- When was Dr. Maréchal Nicolas founded?
- Dr. Maréchal Nicolas was founded on 18-08-2022.
- Is Dr. Maréchal Nicolas still active?
- Yes, Dr. Maréchal Nicolas is an active enterprise in the KBO register.
- What is the turnover of Dr. Maréchal Nicolas?
- The turnover in financial year 2025 is ≈ €150,000. This figure is estimated from the gross margin of €67,544 and 32 comparable companies (NACE 862). It probably lies between €120,000 and €190,000.Financials
- Is Dr. Maréchal Nicolas profitable?
- In financial year 2025, Dr. Maréchal Nicolas made a profit of €50,216.
- Where can I find the annual accounts of Dr. Maréchal Nicolas?
- Dr. Maréchal Nicolas filed 4 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Dr. Maréchal Nicolas due?
- Dr. Maréchal Nicolas must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.